ERLN
Endoregulin
Also known as: C17orf110, ELN, ERLN_HUMAN, SMIM6
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P0DI80
- Gene
- ERLN
- Ensembl
- ENSG00000259120
- Chromosome
- 17
- Canonical length
- 62 aa
- Protein class
- Predicted membrane proteins, Transporters
- Subcellular location
- Nucleoplasm
- Quaternary structure
- Homooligomer
OverviewNCBI Gene
Predicted to act upstream of or within negative regulation of ATPase-coupled calcium transmembrane transporter activity. Predicted to be located in endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
62 residues, UniProt reviewed canonical sequence.
>P0DI80|ERLN
1 MDQLVFKETI WNDAFWQNPW DQGGLAVIIL FITAVLLLIL FAIVFGLLTS TENTQCEAGE
61 EELocalizationUniProt · AlphaFold · HPA
Whether an antibody against ERLN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.54
- Highest tissue expression
- 31 nTPM
Expression across tissuesHPA
Tissue
- stomach: 31 nTPM
- testis: 25 nTPM
- fallopian tube: 23 nTPM
- kidney: 22 nTPM
- spinal cord: 12 nTPM
- gallbladder: 9 nTPM
Single-cell type
- late spermatids: 1,696 nCPM
- early spermatids: 659 nCPM
- epididymal clear cells: 182 nCPM
- endometrial ciliated cells: 181 nCPM
- fallopian tube ciliated cells: 154 nCPM
- neuroendocrine cells: 125 nCPM
Immune cell
- plasmacytoid DC: 34 nTPM
- NK-cell: 0.8 nTPM
- total PBMC: 0.3 nTPM
- myeloid DC: 0.2 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
Brain region
- white matter: 14 nTPM
- pons: 10 nTPM
- basal ganglia: 9.9 nTPM
- medulla oblongata: 9.7 nTPM
- midbrain: 9.6 nTPM
- cerebellum: 8.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.87
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ERLN in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ERLN as an antibody target. Whether an autoantibody or antibody against ERLN could matter depends on whether native ERLN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ERLN is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ERLN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...